WallStSmart

TSS, Inc. Common Stock (TSSI)vsZepp Health Corp (ZEPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Zepp Health Corp generates 5% more annual revenue ($258.90M vs $245.72M). TSSI leads profitability with a 6.2% profit margin vs -15.5%. TSSI earns a higher WallStSmart Score of 65/100 (C+).

TSSI

Buy

65

out of 100

Grade: C+

Growth: 9.3Profit: 6.5Value: 8.7Quality: 5.5
Piotroski: 1/9Altman Z: 2.10

ZEPP

Hold

41

out of 100

Grade: D

Growth: 4.7Profit: 2.0Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

TSSIUndervalued (+79.7%)

Margin of Safety

+79.7%

Fair Value

$39.42

Current Price

$15.32

$24.10 discount

UndervaluedFair: $39.42Overvalued
ZEPPUndervalued (+48.6%)

Margin of Safety

+48.6%

Fair Value

$46.70

Current Price

$17.47

$29.23 discount

UndervaluedFair: $46.70Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

TSSI4 strengths · Avg: 9.5/10
PEG RatioValuation
0.1910/10

Growing faster than its price suggests

Return on EquityProfitability
36.1%10/10

Every $100 of equity generates 36 in profit

EPS GrowthGrowth
380.4%10/10

Earnings expanding 380.4% YoY

Revenue GrowthGrowth
21.8%8/10

Revenue surging 21.8% year-over-year

ZEPP2 strengths · Avg: 10.0/10
Price/BookValuation
1.3x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
43.0%10/10

Revenue surging 43.0% year-over-year

Areas to Watch

TSSI4 concerns · Avg: 3.3/10
P/E RatioValuation
25.3x4/10

Moderate valuation

Market CapQuality
$409.53M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
6.2%3/10

6.2% margin — thin

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

ZEPP4 concerns · Avg: 2.0/10
Market CapQuality
$247.54M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-17.2%2/10

ROE of -17.2% — below average capital efficiency

EPS GrowthGrowth
-68.1%2/10

Earnings declined 68.1%

Profit MarginProfitability
-15.5%1/10

Currently unprofitable

Comparative Analysis Report

WallStSmart Research

Bull Case : TSSI

The strongest argument for TSSI centers on PEG Ratio, Return on Equity, EPS Growth. Revenue growth of 21.8% demonstrates continued momentum. PEG of 0.19 suggests the stock is reasonably priced for its growth.

Bull Case : ZEPP

The strongest argument for ZEPP centers on Price/Book, Revenue Growth. Revenue growth of 43.0% demonstrates continued momentum.

Bear Case : TSSI

The primary concerns for TSSI are P/E Ratio, Market Cap, Profit Margin.

Bear Case : ZEPP

The primary concerns for ZEPP are Market Cap, Return on Equity, EPS Growth.

Key Dynamics to Monitor

TSSI profiles as a growth stock while ZEPP is a hypergrowth play — different risk/reward profiles.

TSSI carries more volatility with a beta of 2.04 — expect wider price swings.

ZEPP is growing revenue faster at 43.0% — sustainability is the question.

Monitor INFORMATION TECHNOLOGY SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

TSSI scores higher overall (65/100 vs 41/100) and 21.8% revenue growth. ZEPP offers better value entry with a 48.6% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

TSS, Inc. Common Stock

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

TSS, Inc. provides integration technology services to implement, operate, and maintain information technology systems to enterprises and users in the United States. The company is headquartered in Round Rock, Texas.

Zepp Health Corp

TECHNOLOGY · CONSUMER ELECTRONICS · China

Zepp Health Corporation, an activity and biometric data-driven company, develops, manufactures and sells smart wearable technology devices in the People's Republic of China. The company is headquartered in Hefei, the People's Republic of China.

Want to dig deeper into these stocks?